Head-to-head · Cost-Efficiency Index
Trimrose vs Lumora
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
Trimrose
Shoppers who want a named medical director and pharmacy partners plus the option to step up to branded GLP-1s on the same platform.
Visit TrimroseLumora
Cost-first shoppers who want physician-led compounded GLP-1 with labs, follow-up, and peptide options.
Visit LumoraThe verdict
Trimrose takes it, leading the Cost-Efficiency Index 50 to 49. TrimRose (trimrose.health) is a LegitScript-verified telehealth platform offering compounded semaglutide (from $269/mo) and tirzepatide (from $359/mo), plus branded Ozempic and Wegovy at much higher prices. Lumora still earns a C — Cost-first shoppers who want physician-led compounded GLP-1 with labs, follow-up, and peptide options.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs Trimrose.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | Trimrose | Lumora |
|---|---|---|
| Cost-Efficiency Index | 50/100 | 49/100 |
| Semaglutide / mo | $269/mo (starting dose, compounded) | $199/mo (starting dose, plus a separate fee, compounded) |
| Tirzepatide / mo | $359/mo (starting dose, compounded) | $299/mo (starting dose, compounded) |
| Semaglutide / yr (modeled) | $3,228 | $2,388 |
| Tirzepatide / yr (modeled) | $4,308 | $3,588 |
| Coverage | Coverage not published | Coverage not published |
| Oral / sublingual | Yes | Yes |
| Brand-name access | Yes | Compounded only |
| Rank here | #415 | #422 |
Trimrose
50/100Where the value is
- LegitScript-verified with a displayed seal
- Named medical directors with public NPI numbers, unusual transparency versus peers
- Four named, identifiable compounding pharmacy partners
The tradeoffs
- All prices are 'starting at' floors -- actual monthly cost rises with dose and is not fully disclosed upfront
- A separate $60 first-visit fee is layered on top of the monthly medication price
Lumora
49/100Where the value is
- Compounded semaglutide (5 dose tiers) and tirzepatide (6 dose tiers) in injectable and sublingual forms
- Physician-founded by board-certified Drs. Sean and Shannon Arora (Arora Health & Aesthetics); clinician reviews every assessment
- LegitScript certified, HIPAA compliant, medications dispensed through licensed U.S. pharmacy partners
The tradeoffs
- Pricing is fully gated behind the assessment — no public pricing; actual monthly costs unverifiable without completing intake
- Compounded medications are not FDA-approved; compounding pharmacy partners not publicly named
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.